J&J's Cordis seeks to boost Cypher stent with DTC ads

Share this article:

With Abbott and Medtronic crowding into a market it has long split with Boston Scientific, Johnson & Johnson's Cordis is looking to raise the profile of its Cypher stent with a consumer advertising campaign – a possible first for the category.

The company launched newspaper ads earlier this month in The New York Times, The Wall Street Journal and USA Today. The ads, by BBDO, show an actual-size image of the stent under headlines reading “Tennis partner,” “Hiking gear” and “Gym Equipment.” Copy advises angina sufferers that a Cypher stent “can help get your blood pumping and your body moving once again. So you can get back to living life – playing tennis, running, working out, even sexual activity – without chest pains.”

“The goal is to help facilitate discussion between patients and physicians about coronary artery disease, the treatment options and of course, Cypher as well,” said Carol Goodrich, director of corporate communications for Cordis.

A revamped product site, featuring new patient information, went live in September, and the firm is employing search engine optimization to boost its rankings in Yahoo and WebMD searches.

On the professional side, the company fielded a massive presence at this week's Transcatheter Cardiovascular Therapeutics conference for interventional cardiologists in Washington, DC. New journal ads, by BBDO's Omnicom sibling Harrison + Star, will debut soon.

Edelman is handling PR for the effort, while interactive is being handled in-house by J&J's global advertising department.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.